nodes	percent_of_prediction	percent_of_DWPC	metapath
Tenofovir—ABCC10—Estradiol—prostate cancer	0.1	0.163	CbGbCtD
Tenofovir—ABCC10—Etoposide—prostate cancer	0.0653	0.107	CbGbCtD
Tenofovir—ABCC10—Docetaxel—prostate cancer	0.0597	0.0977	CbGbCtD
Tenofovir—ABCC4—Conjugated Estrogens—prostate cancer	0.0547	0.0895	CbGbCtD
Tenofovir—ABCC10—Doxorubicin—prostate cancer	0.0445	0.0728	CbGbCtD
Tenofovir—ABCC2—Ethinyl Estradiol—prostate cancer	0.0443	0.0725	CbGbCtD
Tenofovir—SLC22A8—Conjugated Estrogens—prostate cancer	0.0342	0.0559	CbGbCtD
Tenofovir—ABCC2—Conjugated Estrogens—prostate cancer	0.0326	0.0532	CbGbCtD
Tenofovir—SLC22A8—Estradiol—prostate cancer	0.03	0.0491	CbGbCtD
Tenofovir—CYP1A2—Flutamide—prostate cancer	0.0257	0.0419	CbGbCtD
Tenofovir—SLC22A6—Conjugated Estrogens—prostate cancer	0.0238	0.0389	CbGbCtD
Tenofovir—ABCC2—Etoposide—prostate cancer	0.0187	0.0305	CbGbCtD
Tenofovir—CYP1A2—Estrone—prostate cancer	0.0185	0.0303	CbGbCtD
Tenofovir—ABCC2—Docetaxel—prostate cancer	0.0171	0.0279	CbGbCtD
Tenofovir—ABCC2—Doxorubicin—prostate cancer	0.0127	0.0208	CbGbCtD
Tenofovir—CYP1A2—Conjugated Estrogens—prostate cancer	0.0121	0.0198	CbGbCtD
Tenofovir—CYP1A2—Estradiol—prostate cancer	0.0107	0.0174	CbGbCtD
Tenofovir—CYP1A2—Etoposide—prostate cancer	0.00696	0.0114	CbGbCtD
Tenofovir—AK2—prostate gland—prostate cancer	0.00503	0.0654	CbGeAlD
Tenofovir—SLC22A8—urine—prostate cancer	0.00405	0.0526	CbGeAlD
Tenofovir—NME1—prostate gland—prostate cancer	0.00386	0.0502	CbGeAlD
Tenofovir—AK4—prostate gland—prostate cancer	0.00372	0.0484	CbGeAlD
Tenofovir—NME2—prostate gland—prostate cancer	0.00364	0.0473	CbGeAlD
Tenofovir—AK4—seminal vesicle—prostate cancer	0.00315	0.0409	CbGeAlD
Tenofovir—CYP1A2—urine—prostate cancer	0.00277	0.036	CbGeAlD
Tenofovir—NME2—epithelium—prostate cancer	0.00267	0.0348	CbGeAlD
Tenofovir—NME1—renal system—prostate cancer	0.00263	0.0342	CbGeAlD
Tenofovir—AK2—bone marrow—prostate cancer	0.00259	0.0337	CbGeAlD
Tenofovir—AK4—renal system—prostate cancer	0.00254	0.033	CbGeAlD
Tenofovir—AK4—urethra—prostate cancer	0.00249	0.0324	CbGeAlD
Tenofovir—NME2—renal system—prostate cancer	0.00248	0.0322	CbGeAlD
Tenofovir—AK2—testis—prostate cancer	0.00222	0.0288	CbGeAlD
Tenofovir—NME1-NME2—lymph node—prostate cancer	0.00212	0.0276	CbGeAlD
Tenofovir—NME1—bone marrow—prostate cancer	0.00199	0.0259	CbGeAlD
Tenofovir—ABCC10—prostate gland—prostate cancer	0.00176	0.023	CbGeAlD
Tenofovir—NME1—testis—prostate cancer	0.0017	0.0221	CbGeAlD
Tenofovir—S-Adenosylmethionine—GNMT—prostate cancer	0.00168	0.293	CrCbGaD
Tenofovir—AK4—testis—prostate cancer	0.00164	0.0213	CbGeAlD
Tenofovir—AK2—lymph node—prostate cancer	0.00161	0.0209	CbGeAlD
Tenofovir—NME2—testis—prostate cancer	0.0016	0.0208	CbGeAlD
Tenofovir—ABCC10—seminal vesicle—prostate cancer	0.00149	0.0194	CbGeAlD
Tenofovir—ABCC4—prostate gland—prostate cancer	0.00146	0.019	CbGeAlD
Tenofovir—SLC22A8—prostate gland—prostate cancer	0.00145	0.0189	CbGeAlD
Tenofovir—ABCC2—prostate gland—prostate cancer	0.00142	0.0184	CbGeAlD
Tenofovir—Adefovir Dipivoxil—SLC22A3—prostate cancer	0.0013	0.228	CrCbGaD
Tenofovir—NME1—lymph node—prostate cancer	0.00123	0.016	CbGeAlD
Tenofovir—ABCC10—renal system—prostate cancer	0.0012	0.0157	CbGeAlD
Tenofovir—AK4—lymph node—prostate cancer	0.00119	0.0155	CbGeAlD
Tenofovir—ABCC10—urethra—prostate cancer	0.00118	0.0154	CbGeAlD
Tenofovir—NME2—lymph node—prostate cancer	0.00116	0.0151	CbGeAlD
Tenofovir—ABCC4—renal system—prostate cancer	0.000998	0.013	CbGeAlD
Tenofovir—SLC22A8—renal system—prostate cancer	0.00099	0.0129	CbGeAlD
Tenofovir—ABCC2—renal system—prostate cancer	0.000966	0.0126	CbGeAlD
Tenofovir—Adenosine triphosphate—HSPA1A—prostate cancer	0.000948	0.166	CrCbGaD
Tenofovir—NME1—Levonorgestrel—Ethinyl Estradiol—prostate cancer	0.000926	1	CbGdCrCtD
Tenofovir—ABCC10—bone marrow—prostate cancer	0.000909	0.0118	CbGeAlD
Tenofovir—ABCC10—testis—prostate cancer	0.000777	0.0101	CbGeAlD
Tenofovir—ABCC4—bone marrow—prostate cancer	0.000754	0.00982	CbGeAlD
Tenofovir—CYP1A2—renal system—prostate cancer	0.000678	0.00882	CbGeAlD
Tenofovir—ABCC4—testis—prostate cancer	0.000645	0.00839	CbGeAlD
Tenofovir—ABCC2—testis—prostate cancer	0.000624	0.00812	CbGeAlD
Tenofovir—ABCC10—lymph node—prostate cancer	0.000563	0.00733	CbGeAlD
Tenofovir—ABCC4—lymph node—prostate cancer	0.000467	0.00608	CbGeAlD
Tenofovir—ABCC2—lymph node—prostate cancer	0.000452	0.00589	CbGeAlD
Tenofovir—S-Adenosylmethionine—COMT—prostate cancer	0.00043	0.0753	CrCbGaD
Tenofovir—Adenosine monophosphate—PDE4D—prostate cancer	0.000419	0.0733	CrCbGaD
Tenofovir—Adenosine triphosphate—AKT1—prostate cancer	0.000372	0.065	CrCbGaD
Tenofovir—Adenosine monophosphate—SRC—prostate cancer	0.000366	0.0641	CrCbGaD
Tenofovir—S-Adenosylmethionine—CYP2E1—prostate cancer	0.0002	0.035	CrCbGaD
Tenofovir—Headache—Conjugated Estrogens—prostate cancer	0.000115	0.0006	CcSEcCtD
Tenofovir—Muscular weakness—Epirubicin—prostate cancer	0.000115	0.000597	CcSEcCtD
Tenofovir—Mental disorder—Capecitabine—prostate cancer	0.000113	0.000589	CcSEcCtD
Tenofovir—Connective tissue disorder—Prednisone—prostate cancer	0.000113	0.000589	CcSEcCtD
Tenofovir—Blood creatinine increased—Doxorubicin—prostate cancer	0.000113	0.000587	CcSEcCtD
Tenofovir—Malnutrition—Capecitabine—prostate cancer	0.000112	0.000585	CcSEcCtD
Tenofovir—Back pain—Docetaxel—prostate cancer	0.000112	0.000585	CcSEcCtD
Tenofovir—Gastrointestinal pain—Mitoxantrone—prostate cancer	0.000112	0.000584	CcSEcCtD
Tenofovir—Flatulence—Capecitabine—prostate cancer	0.000111	0.000577	CcSEcCtD
Tenofovir—Skin disorder—Etoposide—prostate cancer	0.000111	0.000577	CcSEcCtD
Tenofovir—Nausea—Goserelin—prostate cancer	0.00011	0.000574	CcSEcCtD
Tenofovir—Hyperhidrosis—Etoposide—prostate cancer	0.00011	0.000574	CcSEcCtD
Tenofovir—Pancreatitis—Epirubicin—prostate cancer	0.00011	0.000574	CcSEcCtD
Tenofovir—Hypokalaemia—Doxorubicin—prostate cancer	0.000109	0.00057	CcSEcCtD
Tenofovir—Nausea—Conjugated Estrogens—prostate cancer	0.000109	0.000569	CcSEcCtD
Tenofovir—Back pain—Capecitabine—prostate cancer	0.000109	0.000566	CcSEcCtD
Tenofovir—Anorexia—Etoposide—prostate cancer	0.000109	0.000566	CcSEcCtD
Tenofovir—Hypersensitivity—Estradiol—prostate cancer	0.000108	0.000565	CcSEcCtD
Tenofovir—Abdominal pain—Mitoxantrone—prostate cancer	0.000108	0.000564	CcSEcCtD
Tenofovir—Body temperature increased—Mitoxantrone—prostate cancer	0.000108	0.000564	CcSEcCtD
Tenofovir—Nasopharyngitis—Doxorubicin—prostate cancer	0.000108	0.00056	CcSEcCtD
Tenofovir—Muscular weakness—Doxorubicin—prostate cancer	0.000106	0.000553	CcSEcCtD
Tenofovir—Asthenia—Estradiol—prostate cancer	0.000105	0.00055	CcSEcCtD
Tenofovir—Upper respiratory tract infection—Epirubicin—prostate cancer	0.000104	0.000544	CcSEcCtD
Tenofovir—Pruritus—Estradiol—prostate cancer	0.000104	0.000542	CcSEcCtD
Tenofovir—Immune system disorder—Prednisone—prostate cancer	0.000104	0.000541	CcSEcCtD
Tenofovir—Pancreatitis—Doxorubicin—prostate cancer	0.000102	0.000531	CcSEcCtD
Tenofovir—Weight decreased—Epirubicin—prostate cancer	0.000102	0.00053	CcSEcCtD
Tenofovir—Dyspnoea—Etoposide—prostate cancer	0.000102	0.000529	CcSEcCtD
Tenofovir—Hyperglycaemia—Epirubicin—prostate cancer	0.000101	0.000528	CcSEcCtD
Tenofovir—Hypersensitivity—Mitoxantrone—prostate cancer	0.000101	0.000526	CcSEcCtD
Tenofovir—Pneumonia—Epirubicin—prostate cancer	0.000101	0.000525	CcSEcCtD
Tenofovir—Mental disorder—Prednisone—prostate cancer	0.000101	0.000525	CcSEcCtD
Tenofovir—Diarrhoea—Estradiol—prostate cancer	0.000101	0.000524	CcSEcCtD
Tenofovir—Infestation NOS—Epirubicin—prostate cancer	0.0001	0.000522	CcSEcCtD
Tenofovir—Infestation—Epirubicin—prostate cancer	0.0001	0.000522	CcSEcCtD
Tenofovir—Malnutrition—Prednisone—prostate cancer	0.0001	0.000522	CcSEcCtD
Tenofovir—Decreased appetite—Etoposide—prostate cancer	9.91e-05	0.000516	CcSEcCtD
Tenofovir—Arthralgia—Docetaxel—prostate cancer	9.88e-05	0.000515	CcSEcCtD
Tenofovir—Myalgia—Docetaxel—prostate cancer	9.88e-05	0.000515	CcSEcCtD
Tenofovir—Chest pain—Docetaxel—prostate cancer	9.88e-05	0.000515	CcSEcCtD
Tenofovir—Renal failure—Epirubicin—prostate cancer	9.84e-05	0.000513	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Etoposide—prostate cancer	9.84e-05	0.000513	CcSEcCtD
Tenofovir—Asthenia—Mitoxantrone—prostate cancer	9.83e-05	0.000512	CcSEcCtD
Tenofovir—Fatigue—Etoposide—prostate cancer	9.82e-05	0.000512	CcSEcCtD
Tenofovir—Neuropathy peripheral—Epirubicin—prostate cancer	9.82e-05	0.000512	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	9.81e-05	0.000511	CcSEcCtD
Tenofovir—Pain—Etoposide—prostate cancer	9.74e-05	0.000508	CcSEcCtD
Tenofovir—Dizziness—Estradiol—prostate cancer	9.72e-05	0.000507	CcSEcCtD
Tenofovir—Upper respiratory tract infection—Doxorubicin—prostate cancer	9.66e-05	0.000503	CcSEcCtD
Tenofovir—Sweating—Epirubicin—prostate cancer	9.6e-05	0.0005	CcSEcCtD
Tenofovir—Chest pain—Capecitabine—prostate cancer	9.56e-05	0.000498	CcSEcCtD
Tenofovir—Arthralgia—Capecitabine—prostate cancer	9.56e-05	0.000498	CcSEcCtD
Tenofovir—Myalgia—Capecitabine—prostate cancer	9.56e-05	0.000498	CcSEcCtD
Tenofovir—Haematuria—Epirubicin—prostate cancer	9.55e-05	0.000498	CcSEcCtD
Tenofovir—Anxiety—Capecitabine—prostate cancer	9.53e-05	0.000497	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	9.5e-05	0.000495	CcSEcCtD
Tenofovir—Hepatobiliary disease—Epirubicin—prostate cancer	9.47e-05	0.000494	CcSEcCtD
Tenofovir—Weight decreased—Doxorubicin—prostate cancer	9.4e-05	0.00049	CcSEcCtD
Tenofovir—Sinusitis—Epirubicin—prostate cancer	9.4e-05	0.00049	CcSEcCtD
Tenofovir—Hyperglycaemia—Doxorubicin—prostate cancer	9.38e-05	0.000489	CcSEcCtD
Tenofovir—Diarrhoea—Mitoxantrone—prostate cancer	9.37e-05	0.000488	CcSEcCtD
Tenofovir—Vomiting—Estradiol—prostate cancer	9.35e-05	0.000487	CcSEcCtD
Tenofovir—Pneumonia—Doxorubicin—prostate cancer	9.32e-05	0.000486	CcSEcCtD
Tenofovir—Gastrointestinal pain—Etoposide—prostate cancer	9.32e-05	0.000486	CcSEcCtD
Tenofovir—Nervous system disorder—Docetaxel—prostate cancer	9.29e-05	0.000484	CcSEcCtD
Tenofovir—Rash—Estradiol—prostate cancer	9.27e-05	0.000483	CcSEcCtD
Tenofovir—Infestation NOS—Doxorubicin—prostate cancer	9.27e-05	0.000483	CcSEcCtD
Tenofovir—Infestation—Doxorubicin—prostate cancer	9.27e-05	0.000483	CcSEcCtD
Tenofovir—Dermatitis—Estradiol—prostate cancer	9.26e-05	0.000483	CcSEcCtD
Tenofovir—Headache—Estradiol—prostate cancer	9.21e-05	0.00048	CcSEcCtD
Tenofovir—Skin disorder—Docetaxel—prostate cancer	9.2e-05	0.000479	CcSEcCtD
Tenofovir—Angioedema—Prednisone—prostate cancer	9.14e-05	0.000477	CcSEcCtD
Tenofovir—Renal failure—Doxorubicin—prostate cancer	9.11e-05	0.000475	CcSEcCtD
Tenofovir—Neuropathy peripheral—Doxorubicin—prostate cancer	9.08e-05	0.000473	CcSEcCtD
Tenofovir—Anorexia—Docetaxel—prostate cancer	9.03e-05	0.00047	CcSEcCtD
Tenofovir—Abdominal pain—Etoposide—prostate cancer	9.01e-05	0.000469	CcSEcCtD
Tenofovir—Body temperature increased—Etoposide—prostate cancer	9.01e-05	0.000469	CcSEcCtD
Tenofovir—Nervous system disorder—Capecitabine—prostate cancer	8.99e-05	0.000469	CcSEcCtD
Tenofovir—Hepatitis—Epirubicin—prostate cancer	8.99e-05	0.000469	CcSEcCtD
Tenofovir—Skin disorder—Capecitabine—prostate cancer	8.91e-05	0.000464	CcSEcCtD
Tenofovir—Sweating—Doxorubicin—prostate cancer	8.88e-05	0.000463	CcSEcCtD
Tenofovir—Urinary tract disorder—Epirubicin—prostate cancer	8.88e-05	0.000463	CcSEcCtD
Tenofovir—Hyperhidrosis—Capecitabine—prostate cancer	8.86e-05	0.000462	CcSEcCtD
Tenofovir—Haematuria—Doxorubicin—prostate cancer	8.84e-05	0.00046	CcSEcCtD
Tenofovir—Connective tissue disorder—Epirubicin—prostate cancer	8.83e-05	0.00046	CcSEcCtD
Tenofovir—Urethral disorder—Epirubicin—prostate cancer	8.81e-05	0.000459	CcSEcCtD
Tenofovir—Hepatobiliary disease—Doxorubicin—prostate cancer	8.76e-05	0.000457	CcSEcCtD
Tenofovir—Anorexia—Capecitabine—prostate cancer	8.74e-05	0.000455	CcSEcCtD
Tenofovir—Nausea—Estradiol—prostate cancer	8.73e-05	0.000455	CcSEcCtD
Tenofovir—Vomiting—Mitoxantrone—prostate cancer	8.71e-05	0.000454	CcSEcCtD
Tenofovir—Sinusitis—Doxorubicin—prostate cancer	8.69e-05	0.000453	CcSEcCtD
Tenofovir—Rash—Mitoxantrone—prostate cancer	8.64e-05	0.00045	CcSEcCtD
Tenofovir—Dermatitis—Mitoxantrone—prostate cancer	8.63e-05	0.00045	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Docetaxel—prostate cancer	8.63e-05	0.00045	CcSEcCtD
Tenofovir—Headache—Mitoxantrone—prostate cancer	8.58e-05	0.000447	CcSEcCtD
Tenofovir—Insomnia—Docetaxel—prostate cancer	8.57e-05	0.000446	CcSEcCtD
Tenofovir—Arthralgia—Prednisone—prostate cancer	8.52e-05	0.000444	CcSEcCtD
Tenofovir—Myalgia—Prednisone—prostate cancer	8.52e-05	0.000444	CcSEcCtD
Tenofovir—Anxiety—Prednisone—prostate cancer	8.49e-05	0.000442	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	8.46e-05	0.000441	CcSEcCtD
Tenofovir—Dyspnoea—Docetaxel—prostate cancer	8.44e-05	0.00044	CcSEcCtD
Tenofovir—Hypersensitivity—Etoposide—prostate cancer	8.4e-05	0.000438	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Capecitabine—prostate cancer	8.35e-05	0.000435	CcSEcCtD
Tenofovir—Dyspepsia—Docetaxel—prostate cancer	8.34e-05	0.000434	CcSEcCtD
Tenofovir—Hepatitis—Doxorubicin—prostate cancer	8.32e-05	0.000434	CcSEcCtD
Tenofovir—Insomnia—Capecitabine—prostate cancer	8.29e-05	0.000432	CcSEcCtD
Tenofovir—Decreased appetite—Docetaxel—prostate cancer	8.23e-05	0.000429	CcSEcCtD
Tenofovir—Urinary tract disorder—Doxorubicin—prostate cancer	8.22e-05	0.000428	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Docetaxel—prostate cancer	8.18e-05	0.000426	CcSEcCtD
Tenofovir—Asthenia—Etoposide—prostate cancer	8.18e-05	0.000426	CcSEcCtD
Tenofovir—Connective tissue disorder—Doxorubicin—prostate cancer	8.17e-05	0.000426	CcSEcCtD
Tenofovir—Dyspnoea—Capecitabine—prostate cancer	8.17e-05	0.000426	CcSEcCtD
Tenofovir—Fatigue—Docetaxel—prostate cancer	8.16e-05	0.000426	CcSEcCtD
Tenofovir—Urethral disorder—Doxorubicin—prostate cancer	8.15e-05	0.000425	CcSEcCtD
Tenofovir—Nausea—Mitoxantrone—prostate cancer	8.14e-05	0.000424	CcSEcCtD
Tenofovir—Immune system disorder—Epirubicin—prostate cancer	8.12e-05	0.000423	CcSEcCtD
Tenofovir—Mediastinal disorder—Epirubicin—prostate cancer	8.1e-05	0.000422	CcSEcCtD
Tenofovir—Pain—Docetaxel—prostate cancer	8.1e-05	0.000422	CcSEcCtD
Tenofovir—Dyspepsia—Capecitabine—prostate cancer	8.07e-05	0.000421	CcSEcCtD
Tenofovir—Pruritus—Etoposide—prostate cancer	8.06e-05	0.00042	CcSEcCtD
Tenofovir—Nervous system disorder—Prednisone—prostate cancer	8.01e-05	0.000417	CcSEcCtD
Tenofovir—Decreased appetite—Capecitabine—prostate cancer	7.97e-05	0.000415	CcSEcCtD
Tenofovir—Skin disorder—Prednisone—prostate cancer	7.93e-05	0.000413	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Capecitabine—prostate cancer	7.92e-05	0.000413	CcSEcCtD
Tenofovir—Fatigue—Capecitabine—prostate cancer	7.9e-05	0.000412	CcSEcCtD
Tenofovir—Hyperhidrosis—Prednisone—prostate cancer	7.9e-05	0.000411	CcSEcCtD
Tenofovir—Mental disorder—Epirubicin—prostate cancer	7.88e-05	0.00041	CcSEcCtD
Tenofovir—Pain—Capecitabine—prostate cancer	7.84e-05	0.000409	CcSEcCtD
Tenofovir—Malnutrition—Epirubicin—prostate cancer	7.83e-05	0.000408	CcSEcCtD
Tenofovir—Diarrhoea—Etoposide—prostate cancer	7.8e-05	0.000406	CcSEcCtD
Tenofovir—Anorexia—Prednisone—prostate cancer	7.78e-05	0.000406	CcSEcCtD
Tenofovir—Gastrointestinal pain—Docetaxel—prostate cancer	7.74e-05	0.000404	CcSEcCtD
Tenofovir—Flatulence—Epirubicin—prostate cancer	7.71e-05	0.000402	CcSEcCtD
Tenofovir—Back pain—Epirubicin—prostate cancer	7.57e-05	0.000395	CcSEcCtD
Tenofovir—Dizziness—Etoposide—prostate cancer	7.54e-05	0.000393	CcSEcCtD
Tenofovir—Immune system disorder—Doxorubicin—prostate cancer	7.51e-05	0.000392	CcSEcCtD
Tenofovir—Gastrointestinal pain—Capecitabine—prostate cancer	7.5e-05	0.000391	CcSEcCtD
Tenofovir—Mediastinal disorder—Doxorubicin—prostate cancer	7.5e-05	0.000391	CcSEcCtD
Tenofovir—Abdominal pain—Docetaxel—prostate cancer	7.49e-05	0.00039	CcSEcCtD
Tenofovir—Body temperature increased—Docetaxel—prostate cancer	7.49e-05	0.00039	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Prednisone—prostate cancer	7.44e-05	0.000388	CcSEcCtD
Tenofovir—Insomnia—Prednisone—prostate cancer	7.39e-05	0.000385	CcSEcCtD
Tenofovir—Mental disorder—Doxorubicin—prostate cancer	7.29e-05	0.00038	CcSEcCtD
Tenofovir—Abdominal pain—Capecitabine—prostate cancer	7.25e-05	0.000378	CcSEcCtD
Tenofovir—Body temperature increased—Capecitabine—prostate cancer	7.25e-05	0.000378	CcSEcCtD
Tenofovir—Vomiting—Etoposide—prostate cancer	7.25e-05	0.000378	CcSEcCtD
Tenofovir—Malnutrition—Doxorubicin—prostate cancer	7.24e-05	0.000377	CcSEcCtD
Tenofovir—Dyspepsia—Prednisone—prostate cancer	7.19e-05	0.000375	CcSEcCtD
Tenofovir—Rash—Etoposide—prostate cancer	7.18e-05	0.000374	CcSEcCtD
Tenofovir—Dermatitis—Etoposide—prostate cancer	7.18e-05	0.000374	CcSEcCtD
Tenofovir—Headache—Etoposide—prostate cancer	7.14e-05	0.000372	CcSEcCtD
Tenofovir—Flatulence—Doxorubicin—prostate cancer	7.14e-05	0.000372	CcSEcCtD
Tenofovir—Decreased appetite—Prednisone—prostate cancer	7.1e-05	0.00037	CcSEcCtD
Tenofovir—Fatigue—Prednisone—prostate cancer	7.04e-05	0.000367	CcSEcCtD
Tenofovir—Back pain—Doxorubicin—prostate cancer	7e-05	0.000365	CcSEcCtD
Tenofovir—Hypersensitivity—Docetaxel—prostate cancer	6.98e-05	0.000364	CcSEcCtD
Tenofovir—Asthenia—Docetaxel—prostate cancer	6.79e-05	0.000354	CcSEcCtD
Tenofovir—Nausea—Etoposide—prostate cancer	6.77e-05	0.000353	CcSEcCtD
Tenofovir—Hypersensitivity—Capecitabine—prostate cancer	6.76e-05	0.000352	CcSEcCtD
Tenofovir—Pruritus—Docetaxel—prostate cancer	6.7e-05	0.000349	CcSEcCtD
Tenofovir—Gastrointestinal pain—Prednisone—prostate cancer	6.68e-05	0.000348	CcSEcCtD
Tenofovir—Chest pain—Epirubicin—prostate cancer	6.66e-05	0.000347	CcSEcCtD
Tenofovir—Arthralgia—Epirubicin—prostate cancer	6.66e-05	0.000347	CcSEcCtD
Tenofovir—Myalgia—Epirubicin—prostate cancer	6.66e-05	0.000347	CcSEcCtD
Tenofovir—Anxiety—Epirubicin—prostate cancer	6.64e-05	0.000346	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	6.62e-05	0.000345	CcSEcCtD
Tenofovir—Asthenia—Capecitabine—prostate cancer	6.58e-05	0.000343	CcSEcCtD
Tenofovir—Pruritus—Capecitabine—prostate cancer	6.49e-05	0.000338	CcSEcCtD
Tenofovir—Diarrhoea—Docetaxel—prostate cancer	6.48e-05	0.000338	CcSEcCtD
Tenofovir—Body temperature increased—Prednisone—prostate cancer	6.46e-05	0.000336	CcSEcCtD
Tenofovir—Abdominal pain—Prednisone—prostate cancer	6.46e-05	0.000336	CcSEcCtD
Tenofovir—Diarrhoea—Capecitabine—prostate cancer	6.27e-05	0.000327	CcSEcCtD
Tenofovir—Nervous system disorder—Epirubicin—prostate cancer	6.26e-05	0.000326	CcSEcCtD
Tenofovir—Dizziness—Docetaxel—prostate cancer	6.26e-05	0.000326	CcSEcCtD
Tenofovir—Skin disorder—Epirubicin—prostate cancer	6.2e-05	0.000323	CcSEcCtD
Tenofovir—Hyperhidrosis—Epirubicin—prostate cancer	6.17e-05	0.000322	CcSEcCtD
Tenofovir—Arthralgia—Doxorubicin—prostate cancer	6.17e-05	0.000321	CcSEcCtD
Tenofovir—Myalgia—Doxorubicin—prostate cancer	6.17e-05	0.000321	CcSEcCtD
Tenofovir—Chest pain—Doxorubicin—prostate cancer	6.17e-05	0.000321	CcSEcCtD
Tenofovir—Anxiety—Doxorubicin—prostate cancer	6.14e-05	0.00032	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	6.12e-05	0.000319	CcSEcCtD
Tenofovir—Anorexia—Epirubicin—prostate cancer	6.09e-05	0.000317	CcSEcCtD
Tenofovir—Dizziness—Capecitabine—prostate cancer	6.06e-05	0.000316	CcSEcCtD
Tenofovir—Vomiting—Docetaxel—prostate cancer	6.02e-05	0.000314	CcSEcCtD
Tenofovir—Hypersensitivity—Prednisone—prostate cancer	6.02e-05	0.000314	CcSEcCtD
Tenofovir—Rash—Docetaxel—prostate cancer	5.97e-05	0.000311	CcSEcCtD
Tenofovir—Dermatitis—Docetaxel—prostate cancer	5.97e-05	0.000311	CcSEcCtD
Tenofovir—Headache—Docetaxel—prostate cancer	5.93e-05	0.000309	CcSEcCtD
Tenofovir—Asthenia—Prednisone—prostate cancer	5.86e-05	0.000305	CcSEcCtD
Tenofovir—Vomiting—Capecitabine—prostate cancer	5.83e-05	0.000304	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Epirubicin—prostate cancer	5.82e-05	0.000303	CcSEcCtD
Tenofovir—Nervous system disorder—Doxorubicin—prostate cancer	5.8e-05	0.000302	CcSEcCtD
Tenofovir—Rash—Capecitabine—prostate cancer	5.78e-05	0.000301	CcSEcCtD
Tenofovir—Pruritus—Prednisone—prostate cancer	5.78e-05	0.000301	CcSEcCtD
Tenofovir—Insomnia—Epirubicin—prostate cancer	5.78e-05	0.000301	CcSEcCtD
Tenofovir—Dermatitis—Capecitabine—prostate cancer	5.78e-05	0.000301	CcSEcCtD
Tenofovir—Headache—Capecitabine—prostate cancer	5.74e-05	0.000299	CcSEcCtD
Tenofovir—Skin disorder—Doxorubicin—prostate cancer	5.74e-05	0.000299	CcSEcCtD
Tenofovir—Hyperhidrosis—Doxorubicin—prostate cancer	5.71e-05	0.000298	CcSEcCtD
Tenofovir—Dyspnoea—Epirubicin—prostate cancer	5.69e-05	0.000297	CcSEcCtD
Tenofovir—Anorexia—Doxorubicin—prostate cancer	5.63e-05	0.000294	CcSEcCtD
Tenofovir—Nausea—Docetaxel—prostate cancer	5.63e-05	0.000293	CcSEcCtD
Tenofovir—Dyspepsia—Epirubicin—prostate cancer	5.62e-05	0.000293	CcSEcCtD
Tenofovir—Diarrhoea—Prednisone—prostate cancer	5.59e-05	0.000291	CcSEcCtD
Tenofovir—Decreased appetite—Epirubicin—prostate cancer	5.55e-05	0.000289	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Epirubicin—prostate cancer	5.51e-05	0.000287	CcSEcCtD
Tenofovir—Fatigue—Epirubicin—prostate cancer	5.51e-05	0.000287	CcSEcCtD
Tenofovir—Pain—Epirubicin—prostate cancer	5.46e-05	0.000285	CcSEcCtD
Tenofovir—Nausea—Capecitabine—prostate cancer	5.45e-05	0.000284	CcSEcCtD
Tenofovir—Dizziness—Prednisone—prostate cancer	5.4e-05	0.000281	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Doxorubicin—prostate cancer	5.38e-05	0.000281	CcSEcCtD
Tenofovir—Insomnia—Doxorubicin—prostate cancer	5.35e-05	0.000279	CcSEcCtD
Tenofovir—Dyspnoea—Doxorubicin—prostate cancer	5.27e-05	0.000275	CcSEcCtD
Tenofovir—Gastrointestinal pain—Epirubicin—prostate cancer	5.22e-05	0.000272	CcSEcCtD
Tenofovir—Dyspepsia—Doxorubicin—prostate cancer	5.2e-05	0.000271	CcSEcCtD
Tenofovir—Vomiting—Prednisone—prostate cancer	5.19e-05	0.000271	CcSEcCtD
Tenofovir—Rash—Prednisone—prostate cancer	5.15e-05	0.000268	CcSEcCtD
Tenofovir—Dermatitis—Prednisone—prostate cancer	5.14e-05	0.000268	CcSEcCtD
Tenofovir—Decreased appetite—Doxorubicin—prostate cancer	5.14e-05	0.000268	CcSEcCtD
Tenofovir—Headache—Prednisone—prostate cancer	5.12e-05	0.000267	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Doxorubicin—prostate cancer	5.1e-05	0.000266	CcSEcCtD
Tenofovir—Fatigue—Doxorubicin—prostate cancer	5.1e-05	0.000266	CcSEcCtD
Tenofovir—Pain—Doxorubicin—prostate cancer	5.05e-05	0.000263	CcSEcCtD
Tenofovir—Body temperature increased—Epirubicin—prostate cancer	5.05e-05	0.000263	CcSEcCtD
Tenofovir—Abdominal pain—Epirubicin—prostate cancer	5.05e-05	0.000263	CcSEcCtD
Tenofovir—Nausea—Prednisone—prostate cancer	4.85e-05	0.000253	CcSEcCtD
Tenofovir—Gastrointestinal pain—Doxorubicin—prostate cancer	4.83e-05	0.000252	CcSEcCtD
Tenofovir—Hypersensitivity—Epirubicin—prostate cancer	4.71e-05	0.000245	CcSEcCtD
Tenofovir—Abdominal pain—Doxorubicin—prostate cancer	4.67e-05	0.000243	CcSEcCtD
Tenofovir—Body temperature increased—Doxorubicin—prostate cancer	4.67e-05	0.000243	CcSEcCtD
Tenofovir—Asthenia—Epirubicin—prostate cancer	4.58e-05	0.000239	CcSEcCtD
Tenofovir—Pruritus—Epirubicin—prostate cancer	4.52e-05	0.000236	CcSEcCtD
Tenofovir—Diarrhoea—Epirubicin—prostate cancer	4.37e-05	0.000228	CcSEcCtD
Tenofovir—Hypersensitivity—Doxorubicin—prostate cancer	4.35e-05	0.000227	CcSEcCtD
Tenofovir—Asthenia—Doxorubicin—prostate cancer	4.24e-05	0.000221	CcSEcCtD
Tenofovir—Dizziness—Epirubicin—prostate cancer	4.22e-05	0.00022	CcSEcCtD
Tenofovir—Pruritus—Doxorubicin—prostate cancer	4.18e-05	0.000218	CcSEcCtD
Tenofovir—Vomiting—Epirubicin—prostate cancer	4.06e-05	0.000212	CcSEcCtD
Tenofovir—Diarrhoea—Doxorubicin—prostate cancer	4.04e-05	0.000211	CcSEcCtD
Tenofovir—Rash—Epirubicin—prostate cancer	4.03e-05	0.00021	CcSEcCtD
Tenofovir—Dermatitis—Epirubicin—prostate cancer	4.02e-05	0.00021	CcSEcCtD
Tenofovir—Headache—Epirubicin—prostate cancer	4e-05	0.000209	CcSEcCtD
Tenofovir—Dizziness—Doxorubicin—prostate cancer	3.91e-05	0.000204	CcSEcCtD
Tenofovir—Nausea—Epirubicin—prostate cancer	3.79e-05	0.000198	CcSEcCtD
Tenofovir—Vomiting—Doxorubicin—prostate cancer	3.76e-05	0.000196	CcSEcCtD
Tenofovir—Rash—Doxorubicin—prostate cancer	3.73e-05	0.000194	CcSEcCtD
Tenofovir—Dermatitis—Doxorubicin—prostate cancer	3.72e-05	0.000194	CcSEcCtD
Tenofovir—Headache—Doxorubicin—prostate cancer	3.7e-05	0.000193	CcSEcCtD
Tenofovir—Nausea—Doxorubicin—prostate cancer	3.51e-05	0.000183	CcSEcCtD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—prostate cancer	2.41e-05	0.000213	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PIK3CG—prostate cancer	2.4e-05	0.000213	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—NCOA2—prostate cancer	2.34e-05	0.000207	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—NCOA1—prostate cancer	2.34e-05	0.000207	CbGpPWpGaD
Tenofovir—NME1—Metabolism—CYP1A1—prostate cancer	2.33e-05	0.000206	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—RXRA—prostate cancer	2.32e-05	0.000206	CbGpPWpGaD
Tenofovir—NME1—Metabolism—ERCC2—prostate cancer	2.31e-05	0.000204	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—SLC5A5—prostate cancer	2.31e-05	0.000204	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—HSD17B1—prostate cancer	2.3e-05	0.000204	CbGpPWpGaD
Tenofovir—AK2—Metabolism—PTEN—prostate cancer	2.3e-05	0.000203	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—IL2—prostate cancer	2.3e-05	0.000203	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—prostate cancer	2.29e-05	0.000203	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—EP300—prostate cancer	2.29e-05	0.000203	CbGpPWpGaD
Tenofovir—NME2—Metabolism—INS—prostate cancer	2.28e-05	0.000202	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—CYP2E1—prostate cancer	2.24e-05	0.000199	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—SLC5A5—prostate cancer	2.23e-05	0.000198	CbGpPWpGaD
Tenofovir—NME2—Metabolism—CREBBP—prostate cancer	2.23e-05	0.000197	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—prostate cancer	2.23e-05	0.000197	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—SRC—prostate cancer	2.23e-05	0.000197	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—RXRA—prostate cancer	2.23e-05	0.000197	CbGpPWpGaD
Tenofovir—CYP1A2—Metapathway biotransformation—CYP2E1—prostate cancer	2.21e-05	0.000196	CbGpPWpGaD
Tenofovir—AK2—Metabolism—EP300—prostate cancer	2.19e-05	0.000194	CbGpPWpGaD
Tenofovir—NME1—Metabolism—MTHFR—prostate cancer	2.17e-05	0.000192	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—prostate cancer	2.17e-05	0.000192	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—CYP3A4—prostate cancer	2.16e-05	0.000192	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—ITGB3—prostate cancer	2.15e-05	0.00019	CbGpPWpGaD
Tenofovir—CYP1A2—Metapathway biotransformation—CYP3A4—prostate cancer	2.13e-05	0.000189	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PPARA—prostate cancer	2.13e-05	0.000188	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—CYP1B1—prostate cancer	2.13e-05	0.000188	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PIK3CD—prostate cancer	2.11e-05	0.000187	CbGpPWpGaD
Tenofovir—ABCC2—NRF2 pathway—TGFB1—prostate cancer	2.1e-05	0.000186	CbGpPWpGaD
Tenofovir—CYP1A2—Metapathway biotransformation—CYP1B1—prostate cancer	2.1e-05	0.000186	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—GGT1—prostate cancer	2.06e-05	0.000182	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—HPGD—prostate cancer	2.05e-05	0.000182	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—NCOA1—prostate cancer	2.04e-05	0.00018	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—NCOA1—prostate cancer	2.03e-05	0.00018	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—SRC—prostate cancer	2e-05	0.000177	CbGpPWpGaD
Tenofovir—NME1—Metabolism—CAV1—prostate cancer	2e-05	0.000177	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—CYP19A1—prostate cancer	2e-05	0.000177	CbGpPWpGaD
Tenofovir—NME2—Metabolism—NOS3—prostate cancer	2e-05	0.000177	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—MYC—prostate cancer	1.99e-05	0.000177	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—prostate cancer	1.99e-05	0.000176	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—NCOA1—prostate cancer	1.97e-05	0.000175	CbGpPWpGaD
Tenofovir—CYP1A2—Metapathway biotransformation—CYP19A1—prostate cancer	1.97e-05	0.000175	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—VEGFA—prostate cancer	1.95e-05	0.000173	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—prostate cancer	1.95e-05	0.000173	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—prostate cancer	1.95e-05	0.000173	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—RXRA—prostate cancer	1.94e-05	0.000172	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—RXRA—prostate cancer	1.93e-05	0.000171	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—TNFRSF21—prostate cancer	1.93e-05	0.000171	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—PLAU—prostate cancer	1.89e-05	0.000167	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—RXRA—prostate cancer	1.88e-05	0.000166	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—CYP7B1—prostate cancer	1.88e-05	0.000166	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—COMT—prostate cancer	1.86e-05	0.000165	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—GSTP1—prostate cancer	1.85e-05	0.000164	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—CAV1—prostate cancer	1.85e-05	0.000164	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—prostate cancer	1.84e-05	0.000163	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PIK3CB—prostate cancer	1.84e-05	0.000163	CbGpPWpGaD
Tenofovir—CYP1A2—Metapathway biotransformation—COMT—prostate cancer	1.83e-05	0.000162	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A1—prostate cancer	1.83e-05	0.000162	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PTGS2—prostate cancer	1.83e-05	0.000162	CbGpPWpGaD
Tenofovir—CYP1A2—Metapathway biotransformation—GSTP1—prostate cancer	1.82e-05	0.000162	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PIK3CG—prostate cancer	1.82e-05	0.000161	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—TGFB1—prostate cancer	1.79e-05	0.000159	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—PPARA—prostate cancer	1.77e-05	0.000157	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—ACSL4—prostate cancer	1.74e-05	0.000154	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—HSD17B3—prostate cancer	1.74e-05	0.000154	CbGpPWpGaD
Tenofovir—NME1—Metabolism—INS—prostate cancer	1.72e-05	0.000153	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—PPARA—prostate cancer	1.7e-05	0.000151	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—GSTM1—prostate cancer	1.7e-05	0.000151	CbGpPWpGaD
Tenofovir—NME1—Metabolism—CREBBP—prostate cancer	1.69e-05	0.00015	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—PIK3CG—prostate cancer	1.68e-05	0.000149	CbGpPWpGaD
Tenofovir—CYP1A2—Metapathway biotransformation—GSTM1—prostate cancer	1.68e-05	0.000148	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—EGF—prostate cancer	1.66e-05	0.000147	CbGpPWpGaD
Tenofovir—AK2—Metabolism—PIK3CA—prostate cancer	1.62e-05	0.000143	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—CYP1A1—prostate cancer	1.61e-05	0.000143	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PIK3CD—prostate cancer	1.6e-05	0.000142	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PTEN—prostate cancer	1.59e-05	0.000141	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—HAO1—prostate cancer	1.59e-05	0.000141	CbGpPWpGaD
Tenofovir—CYP1A2—Metapathway biotransformation—CYP1A1—prostate cancer	1.59e-05	0.000141	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—CREBBP—prostate cancer	1.56e-05	0.000138	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—IGF1—prostate cancer	1.54e-05	0.000136	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—prostate cancer	1.52e-05	0.000135	CbGpPWpGaD
Tenofovir—NME2—Metabolism—EP300—prostate cancer	1.52e-05	0.000134	CbGpPWpGaD
Tenofovir—NME1—Metabolism—NOS3—prostate cancer	1.51e-05	0.000134	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B1—prostate cancer	1.48e-05	0.000131	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—PPARA—prostate cancer	1.48e-05	0.000131	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—PIK3CD—prostate cancer	1.48e-05	0.000131	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—SERPINE1—prostate cancer	1.46e-05	0.00013	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—PPARA—prostate cancer	1.43e-05	0.000127	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—TBXAS1—prostate cancer	1.42e-05	0.000126	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.41e-05	0.000125	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—NOS3—prostate cancer	1.4e-05	0.000124	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PIK3CB—prostate cancer	1.4e-05	0.000124	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PTGS2—prostate cancer	1.38e-05	0.000123	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—ABCG5—prostate cancer	1.37e-05	0.000121	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—JAK2—prostate cancer	1.36e-05	0.00012	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.35e-05	0.00012	CbGpPWpGaD
Tenofovir—AK2—Metabolism—AKT1—prostate cancer	1.32e-05	0.000117	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B2—prostate cancer	1.32e-05	0.000117	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CSAD—prostate cancer	1.3e-05	0.000115	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—TST—prostate cancer	1.3e-05	0.000115	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GRHL1—prostate cancer	1.3e-05	0.000115	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CBR1—prostate cancer	1.3e-05	0.000115	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PSAT1—prostate cancer	1.3e-05	0.000115	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—ADI1—prostate cancer	1.3e-05	0.000115	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—PIK3CB—prostate cancer	1.29e-05	0.000114	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—LRP2—prostate cancer	1.27e-05	0.000112	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—AKT1—prostate cancer	1.25e-05	0.00011	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—P4HB—prostate cancer	1.24e-05	0.00011	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PTEN—prostate cancer	1.21e-05	0.000107	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—UGT2B17—prostate cancer	1.21e-05	0.000107	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—UGT2B15—prostate cancer	1.21e-05	0.000107	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GRHPR—prostate cancer	1.21e-05	0.000107	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CKMT2—prostate cancer	1.21e-05	0.000107	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—IL2—prostate cancer	1.18e-05	0.000105	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—SULT2A1—prostate cancer	1.18e-05	0.000104	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.18e-05	0.000104	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—MED12—prostate cancer	1.16e-05	0.000103	CbGpPWpGaD
Tenofovir—NME1—Metabolism—EP300—prostate cancer	1.15e-05	0.000102	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.14e-05	0.000101	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GSTM3—prostate cancer	1.13e-05	0.0001	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—NAGLU—prostate cancer	1.13e-05	0.0001	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PGAM2—prostate cancer	1.13e-05	0.0001	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—MBTPS1—prostate cancer	1.13e-05	0.0001	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—SULT2B1—prostate cancer	1.13e-05	0.0001	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—RFK—prostate cancer	1.13e-05	0.0001	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—AOX1—prostate cancer	1.13e-05	0.0001	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PIK3CA—prostate cancer	1.12e-05	9.95e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—NCOA3—prostate cancer	1.11e-05	9.81e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—AMACR—prostate cancer	1.07e-05	9.51e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CYP3A43—prostate cancer	1.07e-05	9.51e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—SRD5A2—prostate cancer	1.07e-05	9.51e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—NAT1—prostate cancer	1.07e-05	9.51e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—DEGS1—prostate cancer	1.07e-05	9.51e-05	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—EP300—prostate cancer	1.06e-05	9.41e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—prostate cancer	1.06e-05	9.36e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C19—prostate cancer	1.05e-05	9.3e-05	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—SRC—prostate cancer	1.03e-05	9.15e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—HSD17B1—prostate cancer	1.02e-05	9.08e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—prostate cancer	1.02e-05	9.08e-05	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—VEGFA—prostate cancer	1.01e-05	8.91e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—prostate cancer	9.85e-06	8.73e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PRKACB—prostate cancer	9.8e-06	8.68e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—prostate cancer	9.7e-06	8.59e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—NCOA2—prostate cancer	9.24e-06	8.19e-05	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—TGFB1—prostate cancer	9.23e-06	8.18e-05	CbGpPWpGaD
Tenofovir—NME2—Metabolism—AKT1—prostate cancer	9.17e-06	8.12e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—B4GALT4—prostate cancer	9.13e-06	8.09e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—HPGD—prostate cancer	9.13e-06	8.09e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—TNFRSF21—prostate cancer	8.59e-06	7.61e-05	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—KRAS—prostate cancer	8.55e-06	7.57e-05	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PIK3CA—prostate cancer	8.51e-06	7.54e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CYP7B1—prostate cancer	8.35e-06	7.4e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—MTAP—prostate cancer	8.35e-06	7.4e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	8.17e-06	7.23e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—SULT1E1—prostate cancer	8.14e-06	7.21e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—SRD5A1—prostate cancer	8.14e-06	7.21e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	7.91e-06	7e-05	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—PIK3CA—prostate cancer	7.86e-06	6.96e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	7.79e-06	6.9e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—HSD17B3—prostate cancer	7.77e-06	6.88e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—ACSL4—prostate cancer	7.77e-06	6.88e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	7.68e-06	6.8e-05	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—TP53—prostate cancer	7.6e-06	6.73e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—ARG2—prostate cancer	7.45e-06	6.59e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—UMPS—prostate cancer	7.45e-06	6.59e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PHGDH—prostate cancer	7.45e-06	6.59e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	7.41e-06	6.56e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—LDHB—prostate cancer	7.3e-06	6.47e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CYP3A5—prostate cancer	7.17e-06	6.35e-05	CbGpPWpGaD
Tenofovir—NME1—Metabolism—AKT1—prostate cancer	6.95e-06	6.16e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—UCP3—prostate cancer	6.92e-06	6.13e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GSTA3—prostate cancer	6.92e-06	6.13e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PDHA1—prostate cancer	6.92e-06	6.13e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—TCN2—prostate cancer	6.92e-06	6.13e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—SLC22A3—prostate cancer	6.6e-06	5.85e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—HSD3B1—prostate cancer	6.6e-06	5.85e-05	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—AKT1—prostate cancer	6.42e-06	5.68e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—LPL—prostate cancer	6.41e-06	5.67e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—TBXAS1—prostate cancer	6.33e-06	5.61e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GSTA4—prostate cancer	6.33e-06	5.61e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	6.19e-06	5.48e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GSTA2—prostate cancer	6.17e-06	5.46e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—SULT1A1—prostate cancer	6.09e-06	5.4e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—ABCG5—prostate cancer	6.09e-06	5.4e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GSTA1—prostate cancer	5.95e-06	5.27e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—NAT2—prostate cancer	5.89e-06	5.21e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—HSD3B2—prostate cancer	5.89e-06	5.21e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GSTO1—prostate cancer	5.89e-06	5.21e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	5.66e-06	5.01e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PLCB2—prostate cancer	5.64e-06	5e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CYP2C18—prostate cancer	5.64e-06	5e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—LRP2—prostate cancer	5.64e-06	5e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—P4HB—prostate cancer	5.53e-06	4.9e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—SLC22A1—prostate cancer	5.38e-06	4.77e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	5.32e-06	4.71e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—SULT2A1—prostate cancer	5.25e-06	4.65e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—MED12—prostate cancer	5.16e-06	4.57e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GNG5—prostate cancer	5.12e-06	4.53e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—NCOA3—prostate cancer	4.93e-06	4.37e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	4.85e-06	4.29e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—HPGDS—prostate cancer	4.71e-06	4.17e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CYP2C19—prostate cancer	4.68e-06	4.14e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GSTT1—prostate cancer	4.56e-06	4.04e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—ACHE—prostate cancer	4.56e-06	4.04e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CYP2A6—prostate cancer	4.51e-06	4e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	4.49e-06	3.98e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—AKR1C3—prostate cancer	4.39e-06	3.89e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PRKACB—prostate cancer	4.37e-06	3.87e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CYP17A1—prostate cancer	4.32e-06	3.83e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	4.26e-06	3.77e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—NCOA2—prostate cancer	4.12e-06	3.65e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—SLC5A5—prostate cancer	3.93e-06	3.48e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CYP2E1—prostate cancer	3.84e-06	3.4e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—NQO1—prostate cancer	3.79e-06	3.36e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—TH—prostate cancer	3.74e-06	3.31e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	3.71e-06	3.29e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CYP3A4—prostate cancer	3.7e-06	3.28e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	3.68e-06	3.26e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CYP1B1—prostate cancer	3.64e-06	3.22e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GGT1—prostate cancer	3.52e-06	3.12e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—NCOA1—prostate cancer	3.47e-06	3.07e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CYP19A1—prostate cancer	3.42e-06	3.03e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—RXRA—prostate cancer	3.3e-06	2.92e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	3.21e-06	2.84e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—COMT—prostate cancer	3.18e-06	2.81e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GSTP1—prostate cancer	3.16e-06	2.8e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—ITPR1—prostate cancer	3.11e-06	2.76e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	3.06e-06	2.71e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—TYMS—prostate cancer	2.94e-06	2.6e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GSTM1—prostate cancer	2.91e-06	2.57e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—LPL—prostate cancer	2.85e-06	2.53e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CYP1A1—prostate cancer	2.76e-06	2.44e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—ERCC2—prostate cancer	2.73e-06	2.42e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—MTHFR—prostate cancer	2.57e-06	2.28e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PPARA—prostate cancer	2.52e-06	2.23e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CAV1—prostate cancer	2.37e-06	2.1e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.26e-06	2.01e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PIK3CG—prostate cancer	2.16e-06	1.91e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—INS—prostate cancer	2.04e-06	1.81e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CREBBP—prostate cancer	2e-06	1.77e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PIK3CD—prostate cancer	1.9e-06	1.68e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—NOS3—prostate cancer	1.79e-06	1.59e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PIK3CB—prostate cancer	1.65e-06	1.46e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PTGS2—prostate cancer	1.64e-06	1.45e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PTEN—prostate cancer	1.43e-06	1.27e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—EP300—prostate cancer	1.36e-06	1.21e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PIK3CA—prostate cancer	1.01e-06	8.93e-06	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—AKT1—prostate cancer	8.24e-07	7.29e-06	CbGpPWpGaD
